<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Fibromyalgia Public Meeting on Patient-Focused Drug Development</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Fibromyalgia Public Meeting on Patient-Focused Drug Development</h1>
    <p class="timestamp">Published: 2013-09-23 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing a public meeting and an opportunity for public comment on Patient-Focused Drug Development for fibromyalgia. Patient-Focused Drug Development is part of FDA's performance commitments in the fifth authorization of the Prescription Drug User Fee Act (PDUFA V). The public meeting is intended to allow FDA to obtain patients' perspectives on the impact of fibromyalgia on daily life as well as the available therapies for fibromyalgia.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2013-23019</p>
    <p><strong>Publication Date:</strong> 2013-09-23</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2013/09/23/2013-23019/fibromyalgia-public-meeting-on-patient-focused-drug-development">https://www.federalregister.gov/documents/2013/09/23/2013-23019/fibromyalgia-public-meeting-on-patient-focused-drug-development</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2013-23019</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
